Description
Sunekos® Performa (Sunekos® 200) 2 × 3.5 mL
Sunekos® Performa, also known as Sunekos® 200, is an injectable medical device formulated with a patented combination of low-molecular-weight hyaluronic acid and a specific amino acid complex. Developed by Professional Dietetics S.p.A., the product is designed for dermal biostimulation and extracellular matrix support rather than volumetric filling.
Sunekos Performa delivers a balanced HA concentration (200 mg per vial) combined with amino acids that support fibroblast activity and the physiological production of collagen and elastin. Unlike traditional dermal fillers, it is not intended for structural augmentation but for skin quality improvement, elasticity enhancement, and dermal remodelling.
What Sunekos® Performa Is Similar To
Sunekos Performa can be regarded alongside other skin biorevitalisation injectables designed to improve dermal quality rather than restore volume. Compared with cross-linked HA fillers, Sunekos 200 uses non-cross-linked hyaluronic acid combined with amino acids to promote matrix regeneration.
In clinical discussion, topics such as “sunekos performa reviews” often relate to skin texture improvement and elasticity enhancement rather than lift or contour projection. It differs from volumising fillers in rheology, longevity profile, and injection strategy. This comparison is provided for clinical orientation only and does not imply interchangeability.
Treatment Areas / Indications
According to manufacturer documentation, Sunekos Performa is indicated for dermal biostimulation and improvement of skin quality.
Treatment areas may include:
Face • Periorbital area • Neck • Décolletage • Hands
→ Sunekos Performa is intended for intradermal application focused on skin revitalisation and elasticity improvement.
Usage / Administration (IFU-only)
Injection depth: Intradermal.
Volume per point / injection site: Not provided by manufacturer in public documentation.
Needle specification: Refer to packaging.
Frequency / number of sessions: The commonly referenced Sunekos Performa protocol consists of multiple sessions spaced at defined intervals; exact schedule should follow official IFU guidance.
Professional-use disclaimer: Administered only by qualified medical professionals under aseptic conditions.
If any parameter is omitted in the official IFU, it is marked as “not provided by manufacturer.”
Ingredient List
Hyaluronic acid (200 mg per vial)
Amino acid complex (including glycine, L-proline, L-lysine, L-alanine, and L-valine, as per manufacturer formulation)
Sterile water for injection
Other excipients as per IFU.
Lidocaine: Not included.
Presentation & Longevity
Presentation: 2 × 3.5 mL sterile vials
Shelf-life: Refer to packaging for expiry date.
Longevity (treatment duration): Results vary depending on treatment protocol and individual patient factors; maintenance sessions may be recommended according to clinical assessment.
Safety Notes / Contraindications
Use is contraindicated in patients with known hypersensitivity to hyaluronic acid or any component of the product.
Avoid use in patients with active infection or inflammation at the injection site.
Do not inject intravascularly.
Proper intradermal injection technique and anatomical knowledge are essential.
Single use per vial; ensure packaging is intact and within expiry.
Regulatory Status
CE-marked medical device in Europe.
UKCA status: verify via IFU or authorised distributor.
Regulatory classification may vary by jurisdiction; confirm on product packaging or manufacturer documentation.
FAQ
1. What is Sunekos Performa (Sunekos 200)?
Sunekos Performa is a non-cross-linked hyaluronic acid and amino acid injectable designed for dermal biostimulation and improvement of skin elasticity and texture.
2. What is the Sunekos Performa protocol?
The commonly referenced Sunekos Performa protocol involves multiple intradermal sessions spaced over several weeks. Exact scheduling should follow the manufacturer’s official IFU and practitioner assessment.
3. Where are Sunekos Performa injection points?
Injection points are determined by treatment area and practitioner technique. Public documentation specifies intradermal placement; exact point mapping should follow official clinical guidance.
4. How long do results last?
Longevity depends on individual factors and treatment frequency. Maintenance sessions may be required according to practitioner evaluation.
5. Is Sunekos Performa a dermal filler?
No. Unlike cross-linked HA fillers, Sunekos 200 is formulated for dermal biostimulation rather than volumetric augmentation.
